Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)
Ignazio Grattagliano, Agostino Di Ciaula, Jacek Baj, et al.
Methods in molecular biology (2021), pp. 201-246
Open Access | Times Cited: 18

Showing 18 citing articles:

Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 143
New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases
Sisi Chen, Qilong Li, Hanjing Shi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117084-117084
Open Access | Times Cited: 41
Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
Piero Portincasa, Mohamad Khalil, Laura Mahdi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5640-5640
Open Access | Times Cited: 19
The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome
Mohamad Khalil, Harshitha Shanmugam, Hala Abdallah, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3112-3112
Open Access | Times Cited: 44
NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
Piero Portincasa
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 993-1006
Open Access | Times Cited: 26
Microenvironment-induced programmable nanotherapeutics restore mitochondrial dysfunction for the amelioration of non-alcoholic fatty liver disease
Jun Zhang, Wenyi Yang, Yue Zhu, et al.
Acta Biomaterialia (2025)
Closed Access | Times Cited: 1
The role of microbiota in nonalcoholic fatty liver disease
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 7
Closed Access | Times Cited: 29
Mitochondrial hydrogen peroxide production by pyruvate dehydrogenase and α-ketoglutarate dehydrogenase in oxidative eustress and oxidative distress
Olivia Chalifoux, Ben Faerman, Ryan J. Mailloux
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105399-105399
Open Access | Times Cited: 21
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
Federico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 10-19
Closed Access | Times Cited: 12
Morin inhibits oxidative stress and inflammation in the cardiorenal system associated with post-traumatic stress and alcohol use disorders in mice
Benneth Ben‐Azu, Jerome Ndudi Asiwe, Benjamin Oritsemuelebi, et al.
Deleted Journal (2025), pp. 200196-200196
Open Access
Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD
Giovanna Mercurio, Antonia Giacco, Nicla Scopigno, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1214-1214
Open Access
Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis
Yanqin Wang, Jiaqi Bo, Zhonghua Zhao, et al.
Life Sciences (2023) Vol. 332, pp. 122086-122086
Closed Access | Times Cited: 9
Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation
Jing He, Yi-cai Qian, Ying-chuan Yin, et al.
Chemico-Biological Interactions (2024) Vol. 398, pp. 111110-111110
Closed Access | Times Cited: 3
The Involvement of Human Papilloma Virus in Gastrointestinal Cancers
Jacek Baj, Alicja Forma, Iga Dudek, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2607-2607
Open Access | Times Cited: 13
SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice
Zhitao Ren, Gemin Xiao, Y. Chen, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 11, pp. 830-841
Closed Access | Times Cited: 5
Ablating the glutaredoxin-2 (Glrx2) gene protects male mice against non-alcoholic fatty liver disease (NAFLD) by limiting oxidative distress.
Cathryn Grayson, Olivia Chalifoux, Mariana De Sa Tavares Russo, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 1
Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease
Bing Yang, Xi Yang, Xumei Tan, et al.
Canadian Journal of Gastroenterology and Hepatology (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 3
Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment
Chuwei Yu, Jing Chen, Jin Ren
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9841-9853
Closed Access | Times Cited: 1
Page 1

Scroll to top